openPR Logo
Press release

Prof. Varrela Concludes Influential China Academic Tour

06-24-2025 11:44 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Image: https://www.abnewswire.com/upload/2025/06/cec99010da423960bcf4f5a7c443e773.jpg

Professor Juha Varrela, the distinguished authority in orthodontics and the leading innovator behind LM Dental Occlusal Guidance Technology, has successfully wrapped up his influential academic tour across China.

During the four consecutive and eventful days, the professor exemplified his "researcher's meticulous attention to detail, an educator's fervent dedication, and a pioneer's forward-thinking vision" through the following achievements:

Establishing two strategic partnerships with precision and foresight.

Organizing three groundbreaking academic conferences with vigor and innovation.

The participation in four comprehensive discussions with leading medical institutions.

This visit has laid the groundwork for a comprehensive academic framework, merging "Nordic technological excellence, Chinese clinical insights, and global R&D collaboration." As Professor Varrela so eloquently expresses: "Our technology goes beyond mere correction of growth-it releases the latent developmental potential within."By repurposing the eruption guidance appliances as 'biomechanical supports' for natural jaw development, we are shifting the paradigm of healthcare from reactive treatment to proactive health preservation."

The visit has substantially enhanced Sino-Finnish collaboration in the field of early treatments, providing more evidence-based approaches to address craniofacial growth issues in Asian youth.

Media Contact
Company Name: LM Technology (Beijing) Co, Ltd.
Contact Person: Tina.Wang
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=prof-varrela-concludes-influential-china-academic-tour]
City: Beijing
Country: China
Website: https://www.ilmsmile.com.cn

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prof. Varrela Concludes Influential China Academic Tour here

News-ID: 4080515 • Views:

More Releases from ABNewswire

Aneurysmal Subarachnoid Hemorrhage Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | BIT Pharma, Acasti Pharma
Aneurysmal Subarachnoid Hemorrhage Clinical and Non-Clinical Studies, Key Compan …
DelveInsight's, "Aneurysmal Subarachnoid Hemorrhage Pipeline Insight, 2025," report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Aneurysmal Subarachnoid Hemorrhage (ASH) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Aneurysmal Subarachnoid Hemorrhage Pipeline constitutes 8+ key companies
Alpha-1 Antitrypsin Deficiency Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Octapharma, Dicerna Pharmaceut
Alpha-1 Antitrypsin Deficiency Clinical and Non-Clinical Studies, Key Companies, …
DelveInsight's, "Alpha1-Antitrypsin Deficiency (AATD) Pipeline Insight, 2025," report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Alpha1-Antitrypsin Deficiency (AATD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Alpha-1 Antitrypsin Deficiency Pipeline constitutes 12+ key companies continuously
Warm Autoimmune Hemolytic Anemia (wAIHA) Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis
Warm Autoimmune Hemolytic Anemia (wAIHA) Clinical and Non-Clinical Studies, Key …
Warm Autoimmune Hemolytic Anemia (wAIHA) companies are Fostamatinib, Immunovant Sciences GmbH, Apellis Pharmaceuticals, Inc., Bioverativ, and others. Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline constitutes 5+ key companies continuously working towards developing 5+ Warm Autoimmune Hemolytic Anemia (wAIHA) treatment therapies, analyzes DelveInsight. Warm Autoimmune Hemolytic Anemia (wAIHA) Overview: Warm antibody hemolytic anemia is a rare autoimmune condition in which the immune system mistakenly targets and destroys healthy red blood cells, leading to their early
Osteosarcoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | AlaMab Therapeutics, Zentalis Pharmaceuticals
Osteosarcoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Asses …
Osteosarcoma companies are Isofol Medical, Merck, Eisai Co Ltd, Jiangsu Hengrui Medicine, AstraZeneca, Y-mAbs Therapeutics, Innovent Biologics, PersonGen BioTherapeutics (Suzhou), Cellectar Biosciences, Inc., MacroGenics, Shanghai Pharmaceuticals Holding, Celgene, Hutchmed, MedImmune LLC, Lee's Pharmaceutical Limited, EMD Serono, Iovance Biotherapeutics, Inc., BioEclipse Therapeutics, BioAtla, Inc., Celgene, Actuate Therapeutics Inc., and others. Osteosarcoma Pipeline constitutes 25+ key companies continuously working towards developing 30+ Osteosarcoma treatment therapies [https://www.delveinsight.com/report-store/osteosarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr], analyzes DelveInsight. Osteosarcoma Overview: Osteosarcoma, or osteogenic sarcoma, is

All 5 Releases


More Releases for Professor

Author Nkosi Ife Bandele Releases New Literary Novel - Professor Marvel
Author Nkosi Ife Bandele is pleased to announce the release of his new literary novel, Professor Marvel. Published by Crimson Cloak Publishing in March 2022, the book is already receiving rave reviews from readers and reviewers. The Black List says, "Professor Marvel is an outside-the-box and thought-provoking read that keeps the reader in anticipation of what's to come over the course of the story." Dubbed "Professor Marvel," a popular black male
Who is Professor Majic?
Professor Majic, a well experienced New Age music artist that is taking the industry by force. https://youtu.be/0Ox9pySbIaM Anthony Sanchez better known by his stage name Professor Majic is an on the rise sensation. He was born in Los Angeles, but raised in San Bernardino California. Anthony was born into poverty with 5 other siblings and was lucky to still have both of his parents, but beating the odds was going to
Adelphi University Professor Wins 2017 Independent Press Award
After publishing her first novel, The Ropes That Bind, Tracy Stopler submitted hard copies in two categories to the Independent Press Awards Competition: Women’s Issues and Women’s Fiction, the latter for which she was selected as the “Distinguished Favorite” winner. However, Stopler, who is a registered dietician in private practice for 30 years, an adjunct professor at Adelphi University for 20 years, and who recently took on a new role
Cambridge Professor says climate change threat is misunderstood
Invitation to SCI’s Free Public Evening Lecture Wednesday 28 June 2017 Professor Michael J Kelly, Prince Phillip Professor of Technology, Cambridge University will speak on future energy needs and engineering reality. Professor Kelly says that the UK’s rush to counter the effects of climate change has led to a mistaken scramble to invest in pointless alternative energies. To really tackle the problem, the Government will need a radical plan - nothing short
German Professor Kisses Intranet Oracle Awake
A new online service from Germany is now offering support for intranet administrators. The service has been developed by Professor Karsten Wendland, an Information Workflows and Multimedia Systems specialist at Aalen University. Professor Wendland has been studying corporate intranets for 15 years, identifying typical issues and developing solutions. "Today many intranets are overflowing with content. They are jumbled and beyond control. The operation of such an Intranet quickly grinds to
Creative Writing Professor Reveals the Healing Power of Story
Creative writing professor Robert Hammond works tirelessly to provide a platform that allows people to share their stories – tragic, inspirational or thought-provoking –and one way he is doing this is through his latest book, Transformed by Writing: How to Change Your Life and Change the World with the Power of Story. The book can be bought from Amazon.com's online store from the following URL: http://bit.ly/TransformedByWriting The bestselling author, producer and